Navigation Links
Micromet to Present at the BIO CEO and Investor Conference on February 10, 2009
Date:2/5/2009

BETHESDA, Md., Feb. 5 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), today announced that its President and CEO, Dr. Christian Itin, will present at the BIO CEO and Investor Conference at the Waldorf-Astoria in New York City on Tuesday, February 10, 2009. A simultaneous webcast of the presentation will be available on the company's website at www.micromet-inc.com.

    Forum:    The BIO CEO and Investor
    Date:     Tuesday, February 10, 2009
    Time:     2:15 pm, Eastern Time
    Place:    The Waldorf-Astoria
              301 Park Avenue
              New York, NY 10022
    Webcast:  www.micromet-inc.com

About Micromet, Inc.

Micromet, Inc. (www.micromet-inc.com) is a biopharmaceutical company with offices in Bethesda, MD and Munich, Germany. The Company is focused on developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. The Company's novel antibody technology is based on its proprietary BiTE antibody platform, representing a new class of antibodies that specifically activate T cells from the patient's own immune system to eliminate cancer cells or other disease related cells. Four of the Company's antibodies are currently in clinical trials, with the remainder of its product pipeline in preclinical development. The Company's lead program is a BiTE(R) antibody known as blinatumomab, or MT103. It is in a phase 2 clinical trial for the treatment of patients with acute lymphoblastic leukemia and a phase 1 clinical trial for the treatment of patients with non-Hodgkin's lymphoma. Micromet is developing blinatumomab in collaboration with MedImmune, LLC, a subsidiary of AstraZeneca plc. Micromet's second BiTE ant
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
2. Micromet to Present at the Sachs Associates 7th Annual Biotech in Europe Investor Forum
3. Micromet Data Presented at the International AACR-NCI-EORTC Conference Support the Development of Adecatumumab (MT201) in Earlier Stage Cancer Disease Settings
4. Micromet is Presenting Four Posters on BiTE(R) Antibodies at the International AACR-NCI-EORTC Conference
5. Micromet to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on November 7, 2007
6. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
7. Micromet to Present at the 2007 RBC Capital Markets Healthcare Conference on December 12, 2007
8. Micromet to Present at Two Upcoming Investor Conferences
9. Micromet to Present at the Susquehanna Financial Groups SIGnificant Investment Options Conference on March 4, 2008
10. Micromet, Inc. to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results
11. Micromet, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... equipment, trained personnel, and detection dogs to safeguard ... A revolutionary new electronic chip with nano-sized chemical ... easier. , The groundbreaking nanotechnology-inspired sensor, devised by ... School of Chemistry and Center for Nanoscience and ... picks up the scent of explosives molecules better ...
(Date:7/24/2014)... prefer to settle into equilibriuma state of unchanging ... realm of non-equilibrium conditions where new possibilities lie. ... phases, such as temperature fluctuations, freezing and melting, ... their body temperature, airplanes to fly, and the ... But even though these conditions exist naturally and ...
(Date:7/24/2014)... 2014 SRI International has been awarded a ... of Allergy and Infectious Diseases (NIAID), part of the ... potential therapies for HIV infection and AIDS. The contract ... AIDS and the complications and opportunistic infections associated with ... transmission of HIV. According to the ...
(Date:7/24/2014)... 24, 2014  Neogen Corporation (Nasdaq: NEOG ... its potential revenue from new rodenticide research are premature. ... analysts on July 22, 2014, Neogen,s CEO commented about ... research. "It was my intent Tuesday at ... of a new type of rodenticide, but certainly not ...
Breaking Biology Technology:Nano-sized chip 'sniffs out' explosives far better than trained dogs 2New approach to form non-equilibrium structures 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 3Neogen comments on SenesTech 2
... Two physicists from The University of Manchester who discovered ... for their work. , Professor Andre Geim FRS and ... Nanotechnology have been awarded the prestigious Europhysics Prize for ... reveal its remarkable electronic properties. , Graphene is a ...
... Inc.,(Nasdaq: MEDX ) announced today that it is ... at 9:10 a.m. Eastern Time on,Thursday, September 4, 2008. ... in the Investor Relations section of the Medarex website ... will be available,following the event., About Medarex, ...
... presentations included Resverlogix data, TSX Exchange Symbol: ... Corp.,("Resverlogix" or the "Company") (TSX:RVX) is pleased to ... pertaining to its lead compound,RVX-208, at the European ... titled "RVX-208 a novel small molecule that increases,apolipoprotein ...
Cached Biology Technology:Graphene pioneers follow in Nobel footsteps 2Medarex to Present at the Thomas Weisel Partners Healthcare Conference 2ApoA-I Data Presented at European Society of Cardiology Congress 2
(Date:7/24/2014)... central Africa in mid-July 2014, as the annual fire ... indicate areas of increased temperatures, are heavily sprinkled across ... the Congo (northeast), and Zambia (southeast). Thick gray smoke ... areas, especially in the Democratic Republic of the Congo, ... The fire season is an annual event in this ...
(Date:7/24/2014)... a new drug that successfully treated lupus in mice, a ... $250,000 grant to expand his research to a new version ... range of autoimmune diseases., Chandra Mohan, Hugh Roy and Lillie ... published a study in Arthritis Research & Therapy outlining the ... mice and reduced the number of cases of lupus-related kidney ...
(Date:7/24/2014)... eye doctors and scientists from Singapore have developed Asia,s ... of eye disease that affects the cornea called corneal ... of vision. , Called the POLARIS TGFBI (Transforming ... designed to aid in the diagnosis and management of ... family members carrying a TGFBI mutation who may also ...
Breaking Biology News(10 mins):Biomedical engineer looks at new applications for novel lupus drug 2Biomedical engineer looks at new applications for novel lupus drug 3Singapore team develops Asia's first genetic test that can prevent corneal blindness 2Singapore team develops Asia's first genetic test that can prevent corneal blindness 3
... adaptation to be grown in temperate climates decades ago, ... team have completed the first comprehensive genomic analysis of ... an assistant professor in plant breeding and genetics, said ... specific traits will speed up the adaptation of sorghum ...
... to diesel exhaust particles from traffic pollution leads to ... finds that this is due to increased blood levels ... diseases, in children with high diesel exposure. , The ... is published online in the Journal of Allergy ...
... Philadelphia, PA, September 23, 2013 It is often ... never completely eliminate their attraction to the abused substance. ... suggesting that even long-term abstinence from cocaine does not ... Scientists are currently trying to answer some of the ...
Cached Biology News:First look at complete sorghum genome may usher in new uses for food and fuel 2First look at complete sorghum genome may usher in new uses for food and fuel 3First look at complete sorghum genome may usher in new uses for food and fuel 4Addiction: Can you ever really completely leave it behind? 2
Collected from animals of U.S. origin.Collected from animals of U.S. origin. *Can be used in cell growth studies and immunoassays. *Sterility tested, * Mycoplasma tested upon request, *Endoto...
Fetal Calf Serum Replacement (Bistec) serum...
... reagent for Virus isolation ... unique water insoluble Elastomeric ... and chaotropes; Engineered to ... viruses while preserving infectivity; ...
Non-Receptor Tyrosine Kinase Sampler Kit 10 mu g each...
Biology Products: